ENTRADA THERAPEUTICS
Live / Registered — Registered (as of 18 Jun 2024)
What this means for you
Registered since 18 Jun 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Jun 2030: the §8 declaration of use).
Record
- Serial number
- 88904724
- Registration number
- 7422339
- Mark type
- Design + words
- Filed
- 07 May 2020
- Published for opposition
- 16 Mar 2021
- Registered
- 18 Jun 2024
- Next maintenance filing
- §8 declaration of use, due by 18 Jun 2030 (grace period to 18 Dec 2030)
- Attorney of record
- Stephanie H. Bald
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of pharmaceuticals, but not including pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis, all of the foregoing specifically excluding pharmaceutical preparations for the treatment of cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Entrada Therapeutics, Inc., Boston, MA, US
- Entrada Therapeutics, Inc., Boston, MA, US
- Entrada Therapeutics, Inc., Boston, MA, US
Prosecution history
- 18 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Apr 2024 — USE AMENDMENT FILED
- 11 Apr 2024 — TEAS STATEMENT OF USE RECEIVED
- 14 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2023 — SOU EXTENSION 5 GRANTED
- 07 Nov 2023 — SOU EXTENSION 5 FILED
- 13 Nov 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 24 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Jul 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Jul 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED